People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Other Health Care, Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neuronetics, Inc. | — | Other Health Care | Series B | $118.7M | $332.3M | 2009 |
| Preceptis Medical, Inc. | — | Healthtech | Series A | $21.3M | $8.3M | 2011 |
| Personalized Stem Cells, Inc. | — | Biotechnology | Seed | $2.9M | $70.4M | 2020 |
Michael Dale at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Dale on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steve Anderson | 1 | 14 |
| Mark Wagner | 1 | 9 |
| BUZZ BENSON | 1 | 8 |
| P. Sherrill Neff | 1 | 8 |
| Brian Farley | 1 | 5 |
| John Seaberg | 1 | 5 |
| Wilfred Jaeger | 1 | 4 |
| Ron Hunt | 1 | 4 |
| DAN SACHS | 1 | 4 |
| Leslie Bottorff | 1 | 3 |
| Bruce J. Shook | 1 | 3 |
| P. Sherill Neff | 1 | 3 |
| Christopher Geyen | 1 | 3 |
| JOE DELGADO | 1 | 3 |
| Gil Kliman | 1 | 3 |
| Stephen Campe | 1 | 2 |
| Feng Jiang | 1 | 2 |
| Sherill P. Neff | 1 | 2 |
| Michael D. Dale | 1 | 2 |
| Kevin J. Bitterman | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.